Skip to content

Scientific Advisory Committee

Scientific Advisory Committee

OCRA’s Scientific Advisory Committee (SAC) comprises renowned doctors and researchers in the field of gynecologic oncology who help determine which grants we fund. This panel of esteemed experts reviews hundreds of proposals annually, selecting the most innovative and promising.

Meet the SAC

Former Members

  • Jeff Boyd, PhD
  • Carmel J. Cohen, MD
  • Alan D. D’Andrea, MD
  • Ronny I. Drapkin, MD, PhD
  • Annie Ellis
  • Ellen L. Goode, PhD
  • Susan Leighton
  • Ernst Lengyel, MD, PhD
  • Douglas A. Levine, MD
  • Joyce Liu, MD
  • Carolyn Muller, MD, FACOG
  • Kunle Odunsi, MD, PhD
  • Bob Ozols, MD, PhD
  • Daniel J. Powell Jr., PhD
  • Stephen C. Rubin, MD
  • Michael Seiden, MD, PhD
  • Elizabeth Swisher, MD

Related Topics

April Programs: New Offerings, Fresh Topics, and More

April Programs: New Offerings, Fresh Topics, and More

April is a full month at OCRA, with several new programs joining our ongoing lineup of workshops, educational sessions, and community events. Whether you’re looking for practical guidance, clinical information, or simply a chance to connect and create, there’s something here for you. New and Expanded Programs Advanced Care Planning Workshop Series April 6, 13, … Continued

Read more

OCRA’s Advocate’s Corner: March 2026

OCRA’s Advocate’s Corner: March 2026

Written by Julia Thayer, Associate Director, Advocacy This month, more than 120 OCRA Advocate Leaders traveled to Washington, DC for Advocacy Day—braving snowstorms, severe weather, and even a partial government shutdown to make their voices heard on Capitol Hill. We kicked things off with a full day of training, where the group built skills, shared stories, and … Continued

Read more

OCRA’s Spring Advocacy Day Brings Impact to Capitol Hill

OCRA’s Spring Advocacy Day Brings Impact to Capitol Hill

On March 17, 122 Advocate Leaders from nearly 40 states and Washington, DC, converged on Capitol Hill for OCRA’s Spring Advocacy Day. Together, they held 158 meetings with Congressional offices, carrying a clear message: Congress must sustain and build on its commitment to ovarian and gynecologic cancer research. The energy and reach of this year’s … Continued

Read more

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.